HLBBF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

H. Lundbeck A/S (HLBBF) Ownership - Who owns H. Lundbeck A/S?

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Ottiliavej 9

Phone

+45 36301311

Employees

5450

Web

https://www.lundbeck.com

Details

Group

Domestic Stock Funds

Fundamentals

HLBBF

Capitalization

4.85B

P/E Ratio

13.25

Risk (Beta)

N/A

Dividend Yield

0.02

Total Cash

2.88B

Total Cash/Share

2.90

Total Debt

5.22B

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

9.63

Revenue/Share (as % of the share price)

2.82%

Revenue

18.9B

ROE

N/A

Book Value

21B

P/B Ratio

1.51

Cash Flow

N/A

Earnings

2.41

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

996M

Current Ratio

1.50

Current Revenue Per Employee

917090.94

Dividends Per Share - Security

0.58

EBITDA

2.94B

Float

N/A

Float - Current

N/A

Gross Income Margin

79.36

Revenue To Assets

6.65

Shares Held By Institutions

1.31B

Shares Outstanding - Current

993M

Total Liabilities

15.6B

Total Volume MTD

N/A

Value

N/A

Gain YTD

-28.211

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsOther